Canada Life’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,242
| Closed | -$366K | – | 2082 |
|
|
2024
Q3 | $366K | Buy |
5,242
+10
| +0.2% | +$686 | ﹤0.01% | 1730 |
|
|
2024
Q2 | $353K | Buy |
5,232
+232
| +5% | +$15.6K | ﹤0.01% | 1753 |
|
|
2024
Q1 | $345K | Hold |
5,000
| – | – | ﹤0.01% | 1754 |
|
|
2023
Q4 | $309K | Buy |
5,000
+557
| +13% | +$31.2K | ﹤0.01% | 1781 |
|
|
2023
Q3 | $249K | Buy |
4,443
+2,600
| +141% | +$146K | ﹤0.01% | 1821 |
|
|
2023
Q2 | $94K | Sell |
1,843
-146
| -7% | -$7.77K | ﹤0.01% | 1935 |
|
|
2023
Q1 | $109K | Hold |
1,989
| – | – | ﹤0.01% | 1968 |
|
|
2022
Q4 | $125K | Hold |
1,989
| – | – | ﹤0.01% | 1946 |
|
|
2022
Q3 | $140K | Buy |
1,989
+276
| +16% | +$19K | ﹤0.01% | 1935 |
|
|
2022
Q2 | $97K | Hold |
1,713
| – | – | ﹤0.01% | 1923 |
|
|
2022
Q1 | $114K | Hold |
1,713
| – | – | ﹤0.01% | 1964 |
|
|
2021
Q4 | $96K | Hold |
1,713
| – | – | ﹤0.01% | 2017 |
|
|
2021
Q3 | $112K | Hold |
1,713
| – | – | ﹤0.01% | 2033 |
|
|
2021
Q2 | $109K | Buy |
1,713
+13
| +0.8% | +$767 | ﹤0.01% | 2069 |
|
|
2021
Q1 | $101K | Hold |
1,700
| – | – | ﹤0.01% | 2099 |
|
|
2020
Q4 | $85K | Hold |
1,700
| – | – | ﹤0.01% | 2150 |
|
|
2020
Q3 | $87K | Hold |
1,700
| – | – | ﹤0.01% | 2067 |
|
|
2020
Q2 | $59K | Buy |
1,700
+1,021
| +150% | +$35.2K | ﹤0.01% | 2180 |
|
|
2020
Q1 | $17K | Hold |
679
| – | – | ﹤0.01% | 2417 |
|
|
2019
Q4 | $19K | Buy |
+679
| New | +$16.2K | ﹤0.01% | 2511 |
|
Other funds holding AXNX
Canada Life's AXNX Position: Q4 2024 in Review
Canada Life sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 5,242 shares — an estimated $366K sold.
Canada Life first reported a position in AXNX in Q4 2019 and held it in 20 quarters. The position peaked at $366K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.
- Canada Life reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Canada Life sold 5,242 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $366K.
- Canada Life first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 20 quarters.
- Canada Life's Axonics, Inc. Common Stock position peaked at $366K in Q3 2024.
- 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.
Based on Canada Life's 13F filing for Q4 2024, filed 13 Feb 2025.